Shenzhen Kaifa Technology
920029
Shanghai Yongli Belting
300230
Guomai Culture & Media
301052
4
WuHan Hvsen Biotechnology
300871
5
CHANGFU CO.,LTD
871396
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -307.15%-21.31M | -503.44%-7.9M | -264.36%-13.32M | -56.34%-4.13M | 40.97%4.04M | 1,196.82%10.29M | -58.74%1.96M | 1,109.46%8.11M | -1,605.40%-2.64M | 186.23%2.87M |
Net income from continuing operations | -322.52%-45.94M | -759.85%-19.99M | -303.61%-14.28M | -312.73%-12.89M | -73.33%1.21M | 3,831.66%20.64M | -9.32%3.03M | 499.30%7.01M | 779.07%6.06M | 465.13%4.55M |
Operating gains losses | -110.18%-47.48K | -102.42%-13.61K | --0 | -65.32%-17.71K | 51.09%-16.15K | -5.21%466.42K | -22.23%562.06K | -156.91%-51.9K | 96.91%-10.71K | -231.16%-33.03K |
Depreciation and amortization | 16.67%1.29M | 30.07%360.39K | 10.46%305.93K | 13.10%313.1K | 13.05%312.83K | 12.02%1.11M | 10.16%277.08K | -18.60%276.96K | 37.11%276.83K | 41.89%276.71K |
Other non cash items | -88.62%146.83K | -128.57%-118.76K | -126.82%-68.55K | -116.39%-51.01K | 25.27%385.15K | 522.63%1.29M | 203.87%415.74K | 341.27%255.64K | 739.53%311.19K | 30,745,500.00%307.46K |
Change In working capital | 195.06%13.19M | 372.77%8.06M | -272.48%-1.04M | 159.55%5.53M | 128.66%642.19K | -7,863.75%-13.88M | -432.11%-2.95M | 39.83%602.51K | -896.19%-9.29M | 2.93%-2.24M |
-Change in receivables | 1,751.65%6.54M | -1,101.86%-1.49M | -119.77%-101.82K | 1,189.14%6.86M | 394.56%1.26M | 93.32%-395.72K | -49.98%148.35K | 144.99%514.95K | 76.49%-629.83K | 82.07%-429.19K |
-Change in inventory | 239.55%7.27M | 19.61%6.58M | -99.99%296 | 60.24%-1.02M | 139.27%1.7M | 131.11%2.14M | 424.87%5.5M | 191.45%3.54M | 1.36%-2.56M | -437.73%-4.34M |
-Change in prepaid assets | -170.64%-136.43K | -60.17%14.32K | 746.00%195.25K | -449.11%-8.02K | -478.45%-337.98K | 54.80%-50.41K | 76.82%35.95K | 65.58%-30.22K | -98.82%2.3K | 75.59%-58.43K |
-Change in payables and accrued expense | -731.39%-3.44M | 1,201.85%2.89M | -159.71%-1.16M | -67.29%-2.87M | -2,494.11%-2.29M | 252.86%544.25K | 102.44%221.66K | -48.17%1.94M | -126.55%-1.72M | 109.78%95.56K |
-Change in other current liabilities | 101.14%148.67K | 101.09%64.41K | 100.52%28.12K | 100.76%28.12K | -98.61%28.01K | -200.69%-13.06M | -145.59%-5.93M | -60,139.17%-5.44M | -41,447.86%-3.71M | 9,256.45%2.02M |
-Change in other working capital | 192.05%2.82M | --0 | --0 | 479.33%2.54M | -41.94%273K | -9,127.85%-3.06M | -77.39%-2.93M | -95.82%74.8K | -218.80%-670.12K | 1,034.41%470.21K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -307.15%-21.31M | -503.44%-7.9M | -264.36%-13.32M | -56.34%-4.13M | 40.98%4.04M | 1,196.82%10.29M | -58.74%1.96M | 1,109.46%8.11M | -1,605.41%-2.64M | 186.23%2.87M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | -968.09%-3M | 7.58M | -10.59M | 0 | 0 | 81.23%-281.3K | 0 | 0 | 88.70%-124.26K | -1,277.46%-157.04K |
Capital expenditure reported | --0 | --0 | --0 | --0 | --0 | 27.35%-281.3K | --0 | --0 | ---124.26K | ---157.04K |
Net PPE purchase and sale | ---518.19K | --0 | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Net business purchase and sale | ---2.5M | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Net investment purchase and sale | --13.61K | --10.08M | ---- | ---- | ---- | --0 | --0 | ---- | ---- | ---- |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | -968.09%-3M | --7.58M | ---10.59M | --0 | --0 | 81.23%-281.3K | --0 | --0 | 88.70%-124.26K | -1,277.46%-157.04K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 1,029.21%22.48M | -713.59%-545.4K | -55.39%-873.72K | 58.11%-380.33K | 2,852.17%24.28M | -266.02%-2.42M | 98.71%-67.04K | -4,877.75%-562.29K | -114.68%-907.99K | -278.47%-882.32K |
Net issuance payments of debt | 41.42%-1.54M | -494.55%-398.56K | 30.89%-388.59K | 65.90%-380.33K | 57.92%-371.29K | -280.29%-2.63M | 98.71%-67.04K | -4,877.75%-562.29K | -118.03%-1.12M | -278.47%-882.32K |
Net common stock issuance | --16.62M | ---146.84K | ---485.13K | --0 | --17.25M | --0 | --0 | --0 | --0 | --0 |
Proceeds from stock option exercised by employees | 4,145.93%8.8M | --0 | --0 | --0 | --8.8M | 43,713.95%207.24K | --0 | --0 | --207.24K | --0 |
Net other financing activities | ---1.4M | --0 | --0 | --0 | ---1.4M | ---- | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 1,029.21%22.48M | -713.59%-545.4K | -55.39%-873.72K | 58.11%-380.33K | 2,852.17%24.28M | -266.02%-2.42M | 98.71%-67.04K | -4,877.75%-562.29K | -114.68%-907.99K | -278.47%-882.32K |
Net cash flow | ||||||||||
Beginning cash position | 107.83%14.62M | 7.23%13.65M | 640.82%38.43M | 384.59%42.95M | 107.83%14.62M | 11.97%7.04M | 61.32%12.73M | -40.40%5.19M | 157.40%8.86M | 11.97%7.04M |
Current changes in cash | -124.14%-1.83M | -145.55%-861.17K | -428.54%-24.78M | -22.77%-4.51M | 1,450.73%28.32M | 908.62%7.59M | 320.76%1.89M | 1,028.44%7.54M | -169.83%-3.67M | 164.30%1.83M |
End cash Position | -12.53%12.79M | -12.53%12.79M | 7.23%13.65M | 640.82%38.43M | 384.59%42.95M | 107.83%14.62M | 107.83%14.62M | 61.32%12.73M | -40.40%5.19M | 157.40%8.86M |
Free cash flow | -318.16%-21.83M | -503.44%-7.9M | -270.76%-13.84M | -49.32%-4.13M | 49.15%4.04M | 10,467.16%10.01M | -55.05%1.96M | 1,111.71%8.11M | -2,121.38%-2.77M | 181.22%2.71M |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |